Michael Ulz
Stock Analyst at Morgan Stanley
(0.71)
# 4,263
Out of 5,044 analysts
596
Total ratings
37.5%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by Michael Ulz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Reiterated: Hold | $300 | $232.68 | +28.93% | 49 | Oct 9, 2026 | |
| RCKT Rocket Pharmaceuticals | Reiterated: Hold | $5 | $2.56 | +95.31% | 20 | Oct 7, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $95 | $28.51 | +233.22% | 27 | Oct 6, 2026 | |
| GUTS Fractyl Health | Rated: Hold | $24 | $4.42 | +442.99% | 20 | Oct 5, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $137 | $86.01 | +59.28% | 26 | Sep 28, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $45 → $36 | $16.64 | +116.35% | 26 | Sep 9, 2026 | |
| IONS Ionis Pharmaceuticals | Rated: Buy | $110 → $104 | $45.28 | +129.68% | 40 | Sep 9, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $120 | $62.75 | +91.24% | 28 | Aug 31, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $150 | $90.78 | +65.23% | 22 | Aug 24, 2026 | |
| CABA Cabaletta Bio | Rated: Buy | $13 | $1.93 | +573.58% | 22 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $3 | $4.76 | -36.97% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 | $6.39 | +416.43% | 24 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $32 | $9.86 | +224.54% | 34 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 → $20 | $6.34 | +215.46% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $2.64 | +89.39% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $25 | $17.85 | +40.06% | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $27 → $25 | $11.70 | +113.68% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.5803 | +244.65% | 15 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.39 → $0.36 | $0.0002 | +179,900.00% | 13 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $9.05 | n/a | 8 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.18 | n/a | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $5 | $10.99 | n/a | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 | $2.36 | n/a | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.605 | n/a | 18 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3144 | n/a | 3 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $29.73 | n/a | 12 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $23 | $14.62 | n/a | 2 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $4.49 | n/a | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $3 | $23.33 | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $54.80 | n/a | 15 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.07 | n/a | 12 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.11 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $26.40 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.48 | n/a | 13 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $825.03 | n/a | 6 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $69 → $60 | $13.74 | n/a | 2 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.35 | n/a | 3 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.94 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $16.99 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $11.99 | n/a | 1 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $8 | $0.000001 | n/a | 4 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $40 | $2.76 | n/a | 5 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.10 | n/a | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $151.17 | n/a | 1 | May 18, 2010 |
Alnylam Pharmaceuticals
Oct 9, 2026
Reiterated: Hold
Price Target: $300
Current: $232.68
Upside: +28.93%
Rocket Pharmaceuticals
Oct 7, 2026
Reiterated: Hold
Price Target: $5
Current: $2.56
Upside: +95.31%
Viking Therapeutics
Oct 6, 2026
Reiterated: Buy
Price Target: $95
Current: $28.51
Upside: +233.22%
Fractyl Health
Oct 5, 2026
Rated: Hold
Price Target: $24
Current: $4.42
Upside: +442.99%
Mirum Pharmaceuticals
Sep 28, 2026
Reiterated: Buy
Price Target: $137
Current: $86.01
Upside: +59.28%
Dyne Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $45 → $36
Current: $16.64
Upside: +116.35%
Ionis Pharmaceuticals
Sep 9, 2026
Rated: Buy
Price Target: $110 → $104
Current: $45.28
Upside: +129.68%
Arrowhead Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $120
Current: $62.75
Upside: +91.24%
Rhythm Pharmaceuticals
Aug 24, 2026
Reiterated: Buy
Price Target: $150
Current: $90.78
Upside: +65.23%
Cabaletta Bio
Aug 17, 2026
Rated: Buy
Price Target: $13
Current: $1.93
Upside: +573.58%
Aug 12, 2026
Rated: Sell
Price Target: $3
Current: $4.76
Upside: -36.97%
Aug 12, 2026
Rated: Buy
Price Target: $33
Current: $6.39
Upside: +416.43%
Aug 11, 2026
Rated: Buy
Price Target: $25 → $32
Current: $9.86
Upside: +224.54%
Aug 7, 2026
Reiterated: Hold
Price Target: $23 → $20
Current: $6.34
Upside: +215.46%
Aug 7, 2026
Reiterated: Hold
Price Target: $4 → $5
Current: $2.64
Upside: +89.39%
Aug 6, 2026
Rated: Hold
Price Target: $25
Current: $17.85
Upside: +40.06%
Aug 6, 2026
Rated: Buy
Price Target: $27 → $25
Current: $11.70
Upside: +113.68%
Jun 3, 2026
Reiterated: Buy
Price Target: $2
Current: $0.5803
Upside: +244.65%
Jan 8, 2026
Downgraded: Sell
Price Target: $0.39 → $0.36
Current: $0.0002
Upside: +179,900.00%
Mar 11, 2025
Reiterated: Buy
Price Target: $5
Current: $9.05
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $5
Current: $2.18
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $5
Current: $10.99
Upside: n/a
Aug 13, 2024
Reiterated: Sell
Price Target: $0.5
Current: $2.36
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $0.605
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $0.3144
Upside: n/a
Aug 22, 2023
Reiterated: Hold
Price Target: $40
Current: $29.73
Upside: n/a
May 22, 2023
Rated: Buy
Price Target: $60 → $23
Current: $14.62
Upside: n/a
Jan 27, 2023
Downgraded: Hold
Price Target: $3
Current: $4.49
Upside: n/a
Jan 5, 2022
Reiterated: Hold
Price Target: $7 → $3
Current: $23.33
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $54.80
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $1.07
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $36.11
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $26.40
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $15.48
Upside: n/a
Mar 4, 2021
Reiterated: Buy
Price Target: $340
Current: $825.03
Upside: n/a
Mar 1, 2021
Reiterated: Hold
Price Target: $69 → $60
Current: $13.74
Upside: n/a
Feb 16, 2021
Reiterated: Buy
Price Target: n/a
Current: $22.35
Upside: n/a
Jan 29, 2021
Reiterated: Buy
Price Target: $5
Current: $2.94
Upside: n/a
Jan 29, 2021
Reiterated: Buy
Price Target: $37
Current: $16.99
Upside: n/a
Aug 12, 2020
Initiated Coverage: Buy
Price Target: $45
Current: $11.99
Upside: n/a
Jul 30, 2020
Reiterated: Buy
Price Target: $15 → $8
Current: $0.000001
Upside: n/a
Mar 28, 2019
Reiterated: Hold
Price Target: $3 → $40
Current: $2.76
Upside: n/a
Oct 3, 2017
Rated: Buy
Price Target: n/a
Current: $5.10
Upside: n/a
May 18, 2010
Reiterated: Buy
Price Target: $28
Current: $151.17
Upside: n/a